Monica M. Bertagnolli, MD, will serve as the National Cancer Institute (NCI)’s new director, a role critical to ensuring ongoing innovation in oncology.
Cancer Research Funding Press Releases
Today the U.S. Senate Appropriations Committee released its FY 2023 spending bill that includes a $2 billion funding increase for the National Institutes of Health (NIH), including a $291 million funding boost for the National Cancer Institute (NCI).
An article released today in JAMA Network Open details the potential benefits of using technology to increase patient participation in cancer clinical trials. In a survey of nearly 1,200 recent cancer patients and survivors, more than 80% said they would be willing to use remote technologies and tools in a trial.
House Appropriations Committee Prioritizes Medical Research with Significant Increase for NIH in FY 2023 Budget
The House Appropriations Committee will vote today to approve its FY 2023 spending bill including a $2.5 billion funding increase for the National Institutes of Health (NIH), a $466 million funding boost for the National Cancer Institute (NCI) and $2.75 billion for the Advanced Research Projects Agency on Health (ARPA-H).
American Cancer Society and ACS CAN CEO Testifies Before Congress; Advocates for Increased Federal Funding for Medical Research
Dr. Karen E. Knudsen, the Chief Executive Officer of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN), will testify before the House Appropriations Subcommittee on Labor, Health, and Human Services and Education, and related agencies today in support of increased federal funding for the National Institutes of Health (NIH), National Cancer Institute (NCI) and the Centers for the Disease Control and Prevention (CDC).
Eighty-Seven Patient Groups Urge Congress to Pass Legislation That Would Improve Clinical Trial Diversity
Eighty-seven organizations representing patients with chronic and acute health conditions, sent a letter to Congress today urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.
National Cancer Institute (NCI) director, Dr. Ned Sharpless, has announced he intends to leave his post at NCI at the end of April. Dr. Sharpless has led the Institute for five years during which time he proved to be a tireless advocate for increased investment in cancer research.
President’s FY 23 Budget Jeopardizes Essential National Cancer Institute Resources, Boosts ARPA-H Funding
WASHINGTON, D.C.— Monday the Biden administration released its FY 2023 budget, which includes $5 billion for the forthcoming creation of the Advanced Research Project on Health (ARPA-H) but reduces funding by nearly $200 million for the National Cancer Institute (NCI); a scenario
FY22 Omnibus Offers Important Increases to NIH and NCI; Misses Mark on Cancer Prevention Funding and Access to Health Coverage
Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.